Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Income from Continuing Operations (2021 - 2026)

HeartSciences' Income from Continuing Operations history spans 6 years, with the latest figure at 1990449.0 for Q1 2026.

  • For Q1 2026, Income from Continuing Operations rose 21.97% year-over-year to 1990449.0; the TTM value through Jan 2026 reached 8502444.0, up 1.73%, while the annual FY2025 figure was 8853024.0, 32.93% down from the prior year.
  • Income from Continuing Operations reached 1990449.0 in Q1 2026 per HSCS's latest filing, up from 2352937.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 1239354.0 in Q1 2022 to a low of 2550949.0 in Q1 2025.
  • Average Income from Continuing Operations over 5 years is 1854800.24, with a median of 1900727.0 recorded in 2024.
  • Peak YoY movement for Income from Continuing Operations: plummeted 109.25% in 2022, then rose 21.97% in 2026.
  • A 5-year view of Income from Continuing Operations shows it stood at 1807710.0 in 2022, then grew by 3.28% to 1748381.0 in 2023, then fell by 20.26% to 2102631.0 in 2024, then decreased by 11.9% to 2352937.0 in 2025, then increased by 15.41% to 1990449.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Income from Continuing Operations are 1990449.0 (Q1 2026), 2352937.0 (Q4 2025), and 2057807.0 (Q3 2025).